Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 87

Sort by

Sort Order Select

Journal Articles

Serum Proteome Profiling Reveals Inflammatory, Molecular and Prognostic Information Beyond the Ctdna in Aggressive B-Cell Lymphomas

Maare Arffman, Leo Meriranta, Harald Holte, Judit Jørgensen, Peter De Nully Brown, Sirkku Jyrkkio, Mats Jerkeman, Øystein Fluge, Magnus Björkholm, Matias Autio, Suvi-Katri Leivonen, Sirpa Leppa

Blood (2022) 140 (Supplement 1): 1316–1317.

https://doi.org/10.1182/blood-2022-158426

Published: 2022

Journal Articles

Patterns of Childbirth in Women with Myeloproliferative Neoplasms

Anna Ravn Landtblom, Therese M.L. Andersson, Anna L.V. Johansson, Frida E. Lundberg, Jan Samuelsson, Magnus Björkholm, Malin Hultcrantz

Blood (2022) 140 (Supplement 1): 6856–6857.

https://doi.org/10.1182/blood-2022-163823

Published: 2022

Journal Articles

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Blood (2022) 139 (12): 1863–1877.

https://doi.org/10.1182/blood.2021012852

Published: 2022

Includes: Supplemental data

Journal Articles

Diabetes Mellitus and Risk of Plasma Cell and Lymphoproliferative Disorders: A Population Based Study Including 94,579 Cases and 368,348 Matched Controls

Urvi A Shah, MD, Sæmundur Rögnvaldsson, BS, Andriy Derkach, PhD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Yael David, PhD, Malin Hultcrantz, MD PhD, Carlyn Tan, MD, Hani Hassoun, MD, Neha Korde, MD, Alexander M. Lesokhin, MD, Sham Mailankody, MBBS, Sigurður Yngvi Kristinsson, MD PhD, Ola Landgren, MD PhD

Blood (2020) 136 (Supplement 1): 44–45.

https://doi.org/10.1182/blood-2020-141597

Published: 2020

Journal Articles

Healthcare Resource Utilization and Sickness Absence in Newly Diagnosed Multiple Myeloma Patients in Sweden: Trends in a Changing Treatment Landscape

Fredrik Borgsten, MD, Xenia Gatopoulou, MBA, Marta Pisini, MBA, Magnus Tambour, PhD, Frida Schain, PhD, Christina V Jones, PhD, Kelvin Ho Man Kwok, PhD, Catharina Hjortsberg, PhD, Magnus Björkholm, MD PhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-137498

Published: 2020

Journal Articles

Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases

Sæmundur Rögnvaldsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2019) 134 (Supplement_1): 5444.

https://doi.org/10.1182/blood-2019-131514

Published: 2019

Journal Articles

Trends in survival of young adult patients with acute lymphoblastic leukemia in Sweden and the United States

Magnus Björkholm, Gustaf Edgren, Paul W. Dickman

Blood (2019) 134 (4): 407–410.

https://doi.org/10.1182/blood.2019001168

Published: 2019

Includes: Supplemental data

Journal Articles

Peripheral Neuropathy Is Associated with an Increased Risk of Fractures in Individuals with Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study Including 15,351 MGUS Cases

Sæmundur Rögnvaldsson, BS, Sigrun Thorsteinsdottir, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 1914.

https://doi.org/10.1182/blood-2018-99-116740

Published: 2018

Journal Articles

Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis

Gudbjorg Jonsdottir, MD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS, MD FRCPath, MRCP, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4437.

https://doi.org/10.1182/blood-2018-99-111715

Published: 2018

Journal Articles

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Sigrun Thorsteinsdottir, MD, Ingigerdur S Sverrisdottir, MD, Gauti Gislason, MSc, Ola Landgren, MD PhD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Sigurdur Y Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4490.

https://doi.org/10.1182/blood-2018-99-115403

Published: 2018

Journal Articles

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Gudbjorg Jonsdottir, MD, Magnus Bjorkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Ola Landgren, MD PhD, Sigurdur Y. Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4396.

https://doi.org/10.1182/blood.V130.Suppl_1.4396.4396

Published: 2017

Journal Articles

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

Sæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4338.

https://doi.org/10.1182/blood.V130.Suppl_1.4338.4338

Published: 2017

Journal Articles

Caspase-3–dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells

Ioulia Vardaki, Claire Sanchez, Pedro Fonseca, Magnus Olsson, Dimitrios Chioureas, George Rassidakis, Anders Ullén, Boris Zhivotovsky, Magnus Björkholm, Theocharis Panaretakis

Blood (2016) 128 (23): 2655–2665.

https://doi.org/10.1182/blood-2016-05-715961

Published: 2016

Includes: Supplemental data

Journal Articles

Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study

Ebba K Lindqvist, MD, Sigrun H Lund, PhD, Rene Costello, Debra Burton, Neha S Korde, MD, Sham Mailankody, MD, Magnus Björkholm, MD, PhD, Gudny Eiriksdottir, Leonore J Launer, PhD, Tamara B Harris, MD, Malin Hultcrantz, MDPhD, Vilmundur Gudnason, MD PhD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 5650.

https://doi.org/10.1182/blood.V128.22.5650.5650

Published: 2016

Journal Articles

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Blood (2016) 128 (22): 1854.

https://doi.org/10.1182/blood.V128.22.1854.1854

Published: 2016

Journal Articles

No Increased Prevalence of Malignancies Among First-Degree Relatives of Patients with Chronic Myeloid Leukemia - Data from Population-Based Swedish Registries

Niklas Gunnarsson, MD, Martin Höglund, MD PhD, Leif Stenke, MD PhD, Fredrik Sandin, MSc, Magnus Bjorkholm, Arta Dreimane, MD PhD, Mats Lambe, MD PhD, Berit Markevärn, MD, Ulla Olsson-Strömberg, MD PhD, Hans Wadenvik, MD PhD, Johan Richter, MD, Anders Själander, MD PhD

Blood (2016) 128 (22): 1896.

https://doi.org/10.1182/blood.V128.22.1896.1896

Published: 2016

Journal Articles

Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013

Brendan M. Weiss, MD, Sigrun H Lund, PhD, Magnus Bjorkholm, Adam D. Cohen, MD, Laura Dember, MD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 4448.

https://doi.org/10.1182/blood.V128.22.4448.4448

Published: 2016

Journal Articles

Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden

Maria Creignou, MD, Hannah Bower, MSc, Therese M-L Andersson, MSc PhD, Anna Ravn Landtblom, MD, Paul W Dickman, MSc PhD, Magnus Björkholm, MD, PhD, Sigurdur Y Kristinsson, MD, PhD, Malin Hultcrantz, MDPhD

Blood (2016) 128 (22): 946.

https://doi.org/10.1182/blood.V128.22.946.946

Published: 2016

Journal Articles

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Gudbjorg Jonsdottir, MD, Sigrún H. Lund, PhD, Magnus Björkholm, MD, PhD, Ingemar Turesson, MD, PhD, Anders Wahlin, MD, Prof., Malin Hultcrantz, MD, PhD, Anna Porwit, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3246.

https://doi.org/10.1182/blood.V128.22.3246.3246

Published: 2016

Journal Articles

No Risk of Arterial or Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance: Results from a Population-Based Study

Ebba K Lindqvist, MD, Sigrún H. Lund, PhD, Rene Costello, Debra Burton, Neha S Korde, MD, Sham Mailankody, MBBS, Vilmundur Gudnason, MD PhD, Gudny Eiriksdottir, Leonore Launer, PhD, Tamara B Harris, MD, Malin Hultcrantz, MDPhD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD PhD, Magnus Bjorkholm, MD PhD

Blood (2015) 126 (23): 4252.

https://doi.org/10.1182/blood.V126.23.4252.4252

Published: 2015

NARROW

Serum Proteome Profiling Reveals Inflammatory, Molecular and Prognostic Information Beyond the Ctdna in Aggressive B-Cell Lymphomas

Patterns of Childbirth in Women with Myeloproliferative Neoplasms

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Diabetes Mellitus and Risk of Plasma Cell and Lymphoproliferative Disorders: A Population Based Study Including 94,579 Cases and 368,348 Matched Controls

Healthcare Resource Utilization and Sickness Absence in Newly Diagnosed Multiple Myeloma Patients in Sweden: Trends in a Changing Treatment Landscape

Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases

Trends in survival of young adult patients with acute lymphoblastic leukemia in Sweden and the United States

Peripheral Neuropathy Is Associated with an Increased Risk of Fractures in Individuals with Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study Including 15,351 MGUS Cases

Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

Caspase-3–dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells

Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

No Increased Prevalence of Malignancies Among First-Degree Relatives of Patients with Chronic Myeloid Leukemia - Data from Population-Based Swedish Registries

Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013

Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

No Risk of Arterial or Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance: Results from a Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only